Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanoencapsulated Tacrolimus Spray vs Ointment for Oral Lichen Planus
NCT06591884Phase 2Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Tacrolimus Ointment 0.1% Iwaki in oral lichen planus (OLP) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Oral Disease Severity Score at 30 days and Visual Analog Scale Pain Score at 30 days. Started Sep 2024; status: recruiting.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06591884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06591884.